Clinical Trial Update: Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 long-term extension study evaluating the safety and efficacy of filgotinib in adults with rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Filgotinib (filgotinib)

Snippet

Sponsor: Alfasigma S.p.A. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED